Infliximab

• Target:

  Antibacterial|||TNF

• Related Pathways:

  Microbiology/Virology|||Apoptosis

• Purity:

  0.997

• Bioactivity:

  Infliximab is a monoclonal antibody, a human-mouse chimeric monoclonal antibody that inhibits TNF-? and prevents TNF-? from interacting with TNFR1 and TNFR2. Infliximab can be used to treat Crohn's disease and rheumatoid arthritis.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  170277-31-3